Skip to content

An RCT Comparing Xenograft and Allograft for Ridge Preservation

A Prospective, Randomized, Controlled, Multi-center Study With Direct Measure and Histological Evaluation Comparing Xenograft and Allograft for Posterior Buccal Dehiscence Extraction Site Ridge Preservation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02330523
Enrollment
40
Registered
2015-01-05
Start date
2014-04-30
Completion date
2015-12-31
Last updated
2016-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth Loss

Brief summary

To compare the effectiveness of demineralized freeze-dried bone allograft + cross-linked collagen membrane with xenograft + non-cross-linked collagen membrane for posterior extraction socket ridge preservation.

Detailed description

Buccal bony wall loss is a common sequela following tooth extraction, and guided bone regeneration (GBR) is a common treatment for the regeneration of ridge form and volume preservation allowing dental implant placement. Many bone augmentation biomaterials are employed to accomplish GBR, and both the medical/ dental community and, subsequently, patients benefit from understanding whether a given GBR biomaterial might be more efficacious. To this end, a randomized, case series comparison of allograft + x-linked collagen membrane versus xenograft + non-x-linked collagen membrane would be beneficial to both the dental community and patients. The study compares the effectiveness of demineralized freeze-dried bone allograft + x-linked collagen membrane with xenograft + non-x-linked collagen membrane for posterior region extraction socket ridge preservation.

Interventions

DEVICEallograft + x-link collagen membrane

Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic, minimally traumatic extraction with periotomes and flap reflection will be performed. Allograft will be placed according to randomization schedule and in quantity to fill the extraction socket and mimic surrounding ridge dimension. X-link collagen membrane will be trimmed to extend at least 2 mm beyond the margins of the defect, and soft tissue flaps will be re-approximated using resorbable Vicryl® 6-0.

DEVICExenograft + non-x-link collagen

Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic, minimally traumatic extraction with periotomes and flap reflection will be performed. Xenograft will be placed according to randomization schedule and in quantity to fill the extraction socket and mimic surrounding ridge dimension. Non-x-link collagen membrane will be trimmed to extend at least 2 mm beyond the margins of the defect, and soft tissue flaps will be re-approximated using resorbable Vicryl® 6-0.

Sponsors

Geistlich Pharma AG
CollaboratorINDUSTRY
McGuire Institute
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Subjects 18 to 70-yrs of age 2. Subject indicated for posterior tooth extraction (from 1st premolar to 1st molar) intended for implant placement, with adjacent teeth intact (for stent indexing) 3. Subjects with extraction site bony buccal dehiscences at least 1/3 the depth of socket and 1/3 the mesial-distal width of tooth socket 4. Subjects will have read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF). 5. Subjects must be able and willing to follow study procedures and instructions.

Exclusion criteria

1. Subjects with a history of any tobacco use within the last six months. 2. Subjects with healing disorders (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) that could compromise wound healing and/ or preclude implant surgery; or who are currently receiving or have received within two months prior to study entry, systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery. 3. Subjects taking intramuscular or intravenous bisphosphonates. 4. Subjects who have a known allergy or sensitivity to alginate, latex, collagen or acrylic. 5. Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration 6. Subjects participating in other clinical studies involving therapeutic intervention (either medical or dental). 7. Subjects, who in the opinion of the investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Design outcomes

Primary

MeasureTime frameDescription
Bone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 MonthsSix MonthsThe primary efficacy parameter will be ridge volume preservation as measured apico-coronal and buccal-lingual using a preformed and marked stent.

Secondary

MeasureTime frameDescription
New Bone Plus Graft Content at 6-monthsSix MonthsNew bone and graft content are measured as histomorphometric % vital bone and % mineral (graft remnants) from mid-section bone core biopsies. Histomorphometric analyses are performed with imaging software on composite overview scans. The area of new healing (versus old/ original bony tissues) is demarcated in each section. Within this area, the percentage contributions of each tissue type within the overall area of newly healed tissue is computed, i.e., new bone plus graft content added with connective tissue/ marrow elements totals 100% of the new healing area.
Wound Closure at 4-weeks4-weeksSuture line gap will be measured (buccal-lingual) with a UNC-15 Probe, rounding down to the nearest 0.5 mm.

Countries

United States

Participant flow

Recruitment details

Patients were recruited at all 9 investigation sites between October 2013 and June 2014.

Participants by arm

ArmCount
Allograft + X-link Collagen Membrane
Demineralized freeze-dried allograft + x-linked collagen membrane will be used for guided bone regeneration of dehiscence buccal defects post extraction. Guided Bone Regeneration: Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic, minimally traumatic extraction with periotomes and flap reflection will be performed. Test graft materials will be placed according to randomization schedule and in quantity to fill the extraction socket and mimic surrounding ridge dimension. The membranes will be trimmed to extend at least 2 mm beyond the margins of the defect, and soft tissue flaps will be re-approximated using resorbable Vicryl® 6-0.
21
Xenograft + Non-x-link Collagen
Xenograft + non-x-linked collagen membrane will be used for guided bone regeneration of dehiscence buccal defects post extraction. Guided Bone Regeneration: Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic, minimally traumatic extraction with periotomes and flap reflection will be performed. Test graft materials will be placed according to randomization schedule and in quantity to fill the extraction socket and mimic surrounding ridge dimension. The membranes will be trimmed to extend at least 2 mm beyond the margins of the defect, and soft tissue flaps will be re-approximated using resorbable Vicryl® 6-0.
19
Total40

Baseline characteristics

CharacteristicAllograft + X-link Collagen MembraneXenograft + Non-x-link CollagenTotal
Age, Continuous55.9 years
STANDARD_DEVIATION 10.7
55.3 years
STANDARD_DEVIATION 13.3
55.7 years
STANDARD_DEVIATION 11.8
Region of Enrollment
United States
21 participants19 participants40 participants
Sex: Female, Male
Female
10 Participants9 Participants19 Participants
Sex: Female, Male
Male
11 Participants10 Participants21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 210 / 19
serious
Total, serious adverse events
0 / 210 / 19

Outcome results

Primary

Bone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 Months

The primary efficacy parameter will be ridge volume preservation as measured apico-coronal and buccal-lingual using a preformed and marked stent.

Time frame: Six Months

ArmMeasureGroupValue (MEAN)Dispersion
Allograft + X-link Collagen MembraneBone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 MonthsBone Ridge Buccal-Lingual Width4.95 mmStandard Deviation 2.65
Allograft + X-link Collagen MembraneBone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 MonthsBone Ridge Apico-Coronal Height5.29 mmStandard Deviation 3.73
Xenograft + Non-x-link CollagenBone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 MonthsBone Ridge Buccal-Lingual Width6.71 mmStandard Deviation 2.07
Xenograft + Non-x-link CollagenBone Ridge Buccal-Lingual and Apico-Coronal Measures at 6 MonthsBone Ridge Apico-Coronal Height6.24 mmStandard Deviation 2.98
Secondary

New Bone Plus Graft Content at 6-months

New bone and graft content are measured as histomorphometric % vital bone and % mineral (graft remnants) from mid-section bone core biopsies. Histomorphometric analyses are performed with imaging software on composite overview scans. The area of new healing (versus old/ original bony tissues) is demarcated in each section. Within this area, the percentage contributions of each tissue type within the overall area of newly healed tissue is computed, i.e., new bone plus graft content added with connective tissue/ marrow elements totals 100% of the new healing area.

Time frame: Six Months

ArmMeasureValue (MEAN)Dispersion
Allograft + X-link Collagen MembraneNew Bone Plus Graft Content at 6-months46.14 percentage of total areaStandard Deviation 7.66
Xenograft + Non-x-link CollagenNew Bone Plus Graft Content at 6-months49.21 percentage of total areaStandard Deviation 8.27
Secondary

Wound Closure at 4-weeks

Suture line gap will be measured (buccal-lingual) with a UNC-15 Probe, rounding down to the nearest 0.5 mm.

Time frame: 4-weeks

ArmMeasureValue (MEDIAN)Dispersion
Allograft + X-link Collagen MembraneWound Closure at 4-weeks2.26 mmStandard Deviation 2.68
Xenograft + Non-x-link CollagenWound Closure at 4-weeks0.79 mmStandard Deviation 1.55

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026